We are thrilled to share a comprehensive review of implantable brain–computer interfaces (iBCIs) published in Nature Portfolio Reviews Bioengineering, authored by BCI pioneer Ian Burkhart and colleagues. This landmark paper highlights the incredible strides our field has made over the past 25 years—a journey we are proud to be a part of!
?
Key insights from the review:?
-Global Collaboration: 21 research groups worldwide have worked with 67 participants to restore or rehabilitate motor, sensory, or speech functions using iBCIs.?
-Advancement Priorities: Emphasizes the importance of improving participant diversity, fostering data sharing, and enhancing collaborative research to accelerate iBCI translation and commercialization.?
-Increasing Longevity: Participation durations average over three years, with some extending beyond nine—showcasing the technology’s long-term viability and potential as a lifetime solution.?
-Technological Advancements: Integration of machine learning and AI has dramatically improved decoding speed and accuracy, enabling more precise connections between the brain and external devices.?
?
As for Blackrock Neurotech:??
-Our NeuroPort microelectrode array has been used by 13 research groups and implanted in 38 of the 67 participants as of December 2023 and growing today, demonstrating the trust placed in our technology.?
-Offering the highest spatial resolution among iBCI electrodes, the NeuroPort enables precise neuronal-level measurements—a critical factor in restoring motor control for those affected by spinal cord injuries, stroke, ALS, and other conditions.?
?
Congratulations to Ian Burkhart, Michelle P., Jose L Contreras-Vidal, Ph.D.s, and all the researchers, participants, and collaborators who have contributed to this remarkable field. Together, we’re unlocking human potential by bridging the gap between the brain and technology, poised to lead the future of neurotechnology.
?? Read the full paper here:??https://lnkd.in/gwcSsC_T
#BCI #Braincomputerinterface #Medtech #Neurotech